Emily S. Van Laar

Professional educational needs for chemotherapy-induced nausea and vomiting (CINV): multinational survey results from 2,388 health care providers

Emily S. Van Laar, Jayashri Mehta Desai, Aminah Jatoi · Supportive Care in Cancer · 2014 · 71 citations · Full text

Professional Educational Needs, Chemotherapy-induced Nausea, Patient Safety +7

Ovarian tumor growth regression using a combination of vascular targeting agents anginex or topomimetic 0118 and the chemotherapeutic irofulven

Ruud P.M. Dings, Emily S. Van Laar, Jeremy Webber et al. · Cancer Letters · 2008 · 47 citations · Full text

Oncology, Angiogenesis, Chemotherapeutic Irofulven +12

Inhibiting Tumor Growth by Targeting Tumor Vasculature with Galectin-1 Antagonist Anginex Conjugated to the Cytotoxic Acylfulvene, 6-Hydroxylpropylacylfulvene

Ruud P.M. Dings, Emily S. Van Laar, Melissa Loren et al. · Bioconjugate Chemistry · 2009 · 43 citations

Parent Anginex, Pharmacotherapy, Tumor Biology +17

ATM-dependent CHK2 Activation Induced by Anticancer Agent, Irofulven

Jian Wang, Timothy D. Wiltshire, Yutian Wang et al. · Journal of Biological Chemistry · 2004 · 43 citations · Full text

Characterizations of irofulven cytotoxicity in combination with cisplatin and oxaliplatin in human colon, breast, and ovarian cancer cells

Maria Serova, Fabien Calvo, François Lokiec et al. · Cancer Chemotherapy and Pharmacology · 2005 · 41 citations

Oncology, Medicine, Pathology +8